GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » KP Tissue Inc (TSX:KPT) » Definitions » Intrinsic Value: Projected FCF

KP Tissue (TSX:KPT) Intrinsic Value: Projected FCF : C$5.57 (As of May. 25, 2025)


View and export this data going back to 2012. Start your Free Trial

What is KP Tissue Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2025-05-25), KP Tissue's Intrinsic Value: Projected FCF is C$5.57. The stock price of KP Tissue is C$8.93. Therefore, KP Tissue's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for KP Tissue's Intrinsic Value: Projected FCF or its related term are showing as below:

During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of KP Tissue was 1.97. The lowest was 0.98. And the median was 1.64.

TSX:KPT's Price-to-Projected-FCF is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 1.07
* Ranked among companies with meaningful Price-to-Projected-FCF only.

KP Tissue Intrinsic Value: Projected FCF Historical Data

The historical data trend for KP Tissue's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

KP Tissue Intrinsic Value: Projected FCF Chart

KP Tissue Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.47 6.17 5.96 5.49 5.57

KP Tissue Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 5.57 -

Competitive Comparison of KP Tissue's Intrinsic Value: Projected FCF

For the Household & Personal Products subindustry, KP Tissue's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


KP Tissue's Price-to-Projected-FCF Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, KP Tissue's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where KP Tissue's Price-to-Projected-FCF falls into.


;
;

KP Tissue Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get KP Tissue's Free Cash Flow(6 year avg) = C$0.00.

KP Tissue's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Dec24)*0.8)/Shares Outstanding (Diluted Average)
=(9.5203515959648*0+69.517*0.8)/9.977
=5.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


KP Tissue  (TSX:KPT) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

KP Tissue's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=8.93/5.5741806154155
=1.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


KP Tissue Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of KP Tissue's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


KP Tissue Business Description

Traded in Other Exchanges
Address
2 Prologis Boulevard, Suite 500, Mississauga, ON, CAN, L5W 0G8
KP Tissue Inc is a holding company. Through its equity holdings in Kruger Products Inc. (the operating company), it is involved in the business of producing, distributing, marketing, and selling various disposable tissue products, including bathroom tissue, facial tissue, paper towels, and napkins for both the consumer and away-from-home markets in North America. The products are marketed under several trademarks, such as Cashmere, Purex, SpongeTowels, Esteem, White Swan, Embassy, and others. A majority of its revenue is generated from the sale of tissue products in the consumer market. Geographically, the company derives maximum revenue from Canada and the rest from the United States.
Executives
Mario Gosselin Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Michael Keays Senior Officer
David A Spraley Director, Director or Senior Officer of 10% Security Holder, Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Sarah Astrea Kruger Director, Director or Senior Officer of 10% Security Holder, Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Dino Joe Bianco Director, Senior Officer
David Angel Director or Senior Officer of 10% Security Holder
Michel Letellier Director

KP Tissue Headlines

No Headlines